Search All News
With $16 million gift, Columbia will open a new center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.
A collaboration between Observational Health Data Sciences and Informatics (OHDSI) and Health Level Seven International (HL7) will improve access and sharing of health care data among researchers.
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
- October 2, 2019
Only select neurons die during Parkinson’s disease. Columbia researchers are looking for clues in immune cells to find out what makes these brain cells so vulnerable.
- September 12, 2019
Adrenaline is considered crucial in triggering a “fight or flight” response, but new research shows the response can’t even get started without a hormone made in bone.
- August 30, 2019
CUIMC biologists developed a computer algorithm that uncovered previously unknown interactions between viruses and human proteins, providing new insights into Zika and HPV.
- August 20, 2019
Synthetic biologists at Columbia have created a technique that could prevent human-engineered proteins from spreading into the wild or mutating.
- August 19, 2019
Columbia pediatricians will mine a trove of health data collected by New York City to address some of the city’s most pressing health inequities.
- August 15, 2019
By participating in one of the world’s largest genetic studies, New Yorkers will help bring precision medicine to their communities, Columbia’s David Goldstein explains.